Head-To-Head Survey: OSR (OSRH) vs. Its Competitors

OSR (NASDAQ:OSRH) is one of 89 public companies in the “UNCLASSIFIED” industry, but how does it compare to its peers? We will compare OSR to related companies based on the strength of its institutional ownership, dividends, profitability, risk, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

55.3% of OSR shares are held by institutional investors. Comparatively, 52.0% of shares of all “UNCLASSIFIED” companies are held by institutional investors. 60.6% of OSR shares are held by insiders. Comparatively, 42.4% of shares of all “UNCLASSIFIED” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

OSR has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, OSR’s peers have a beta of -0.11, indicating that their average share price is 111% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for OSR and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OSR	1	0	0	0	1.00
OSR Competitors	206	262	217	3	2.02

As a group, “UNCLASSIFIED” companies have a potential upside of 65.42%. Given OSR’s peers stronger consensus rating and higher probable upside, analysts plainly believe OSR has less favorable growth aspects than its peers.

Valuation and Earnings

This table compares OSR and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
OSR	N/A	-$2.41 million	-0.64
OSR Competitors	$47.83 million	-$19.62 million	94.60

OSR’s peers have higher revenue, but lower earnings than OSR. OSR is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares OSR and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
OSR	N/A	-12.19%	-8.18%
OSR Competitors	0.86%	0.95%	0.80%

Summary

OSR peers beat OSR on 9 of the 13 factors compared.

OSR Company Profile

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.